KindlyMD Research and Development Expenses 2024-2024 | KDLY
KindlyMD research and development expenses from 2024 to 2024. Research and development expenses can be defined as an expense arising from studies and product development processes.
| KindlyMD Annual Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2024 | $0 |
| 2023 | $0 |
| KindlyMD Quarterly Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2024-12-31 | |
| 2024-09-30 | |
| 2024-06-30 | |
| 2024-03-31 | |
| 2023-12-31 | $0 |
| 2023-09-30 | |
| 2023-06-30 | |
| 2023-03-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.013B | $0.003B |
| KindlyMD Inc. is a patient-first healthcare and healthcare data company uniquely integrating traditional primary care and pain management strategies with integrated behavioral and alternative therapies, including the recommendation of medical cannabis in patient treatment plans in compliance with a legalized state medical cannabis regulatory scheme. KindlyMD Inc. is based in SALT LAKE CITY, UT. | |||